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Trametes species have been used for thousands of years in traditional and conventionalmedicine for the treatment of various types of
diseases. The goal was to evaluate possible antigenotoxic effects of mycelium and basidiocarp extracts of selected Trametes species
and to assess dependence on their antioxidant potential. Trametes versicolor, T. hirsuta, and T. gibbosa were the species studied.
Antigenotoxic potentials of extracts were assessed on human peripheral white blood cells with basidiocarp and mycelium extracts
of the species. The alkaline comet test was used for detection of DNA strand breaks and alkali-labile sites, as well as the extent of
DNA migration. DPPH assay was used to estimate antioxidative properties of extracts. Fruiting body extracts of T. versicolor and
T. gibbosa as well as T. hirsuta extracts, except that at 20.0mg/mL, were not genotoxic agents. T. versicolor extract had at 5.0mg/mL
the greatest antigenotoxic effect in both pre- and posttreatment of leukocytes. The mycelium extracts of the three species had
no genotoxic activity and significant antigenotoxic effect against H
2
O
2
-induced DNA damage, both in pre- and posttreatment.The
results suggest that extracts of these three species could be considered as strong antigenotoxic agents able to stimulate genoprotective
response of cells.
1. Introduction
Mushrooms have long been used as a food but equally in
traditional medicine of both the western and eastern worlds
[1]. Even though numerous mushrooms are recognized as
healthy food [2, 3], their great pharmacological potential is
still underutilized [4]. Nearly 60 Trametes species are known
to inhabit the world but just a few of them are screened
for their medicinal properties [5]. Trametes versicolor (L.:Fr.)
Lloyd is the most famous medicinal species from the genus.
This species, whose folk names are Turkey Tail in west-
ern cultures, Yun-Zhi (cloud-like mushroom) in China, or
Kawaratake (mushroom by the river bank) in Japan, has
been used for thousands of years in traditional medicine,
particularly in Asia [6–8]. According to the Compendium of
Chinese Materia Medica, written during the Ming Dynasty,
more than 120 strains of T. versicolor have been recorded and
in traditional Chinese medicinal practice this mushroom is
considered useful for removing toxins, strengthening, energy
increasing, improvement of liver and spleen function, and
enhancing of the immune response, especially when it is
dried, ground, and prepared into tea [7, 9–11]. All those
properties were considered very useful in folk medicine for
chronic use of Trametes spp. preparations [10]. In conven-
tional medicine the species is used mainly for the treatment
of various types of cancers, but also for chronic hepatitis,
rheumatoid arthritis, and infections of the respiratory, uri-
nary, and digestive tracts, which was confirmed by numerous
studies [6, 10–14]. Additionally, strong antiviral effects of
some polysaccharopeptides isolated from T. versicolor and
significant antioxidant activity of Trametes spp. fruiting body
extracts have been reported [15–17]. These effects are mainly
based on production of the polysaccharide krestin (PSK)
and various polysaccharide-peptide complexes, compounds
which reduce cancermetastases and stimulate the production
of interleukin-1 in human cells [18–20].
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The abundant presence of free radicals in the environ-
ment is associated with the appearance of oxidative stress
which is a basis of aging and the initiation and progress of
various diseases and disorders from which a large part of the
world’s population suffers and dies [21]. DNA is more sensi-
tive to oxidative damage than other macromolecules. DNA
damage, such as strand breaks, could be induced by various
agents among which H
2
O
2
produces a genotoxic effect. It is
known that those damages can affect the immune response
not only in inflammatory diseases but also in cancers [22, 23].
The comet test is a well-established and effective test of high
sensitivity that has been used for examining DNA damage
and can be applied to assess the genotoxic and protective
potential of several natural products [24–26].
A genoprotective activity of mushroom extracts based
on the reduction of oxidative damages of DNA can also
play a significant role in prevention and treatment of several
mentioned diseases and disorders but very few studies until
nowadays considered it as a possible tool of action in different
therapies [27, 28]. Therefore the goal of the study was to
evaluate antigenotoxic effects of mycelium and basidiocarp
extracts of selected Trametes species on human peripheral
white blood cells and to assess dependence on their antiox-
idant potential.
2. Materials and Methods
2.1. Organisms and Cultivation Conditions. Cultures ofTram-
etes versicolor BEOFB 321, T. hirsuta BEOFB 301, and T.
gibbosa BEOFB 310 were isolated from fruiting bodies col-
lected from Serbia and maintained on Malt agar medium in
the culture collection of the Institute of Botany, Faculty of
Biology, University of Belgrade (BEOFB).
The inoculum was prepared by inoculation of 100.0mL
of synthetic medium (glucose, 10.0 g L−1; NH
4
NO
3
, 2.0 g L−1;
K
2
HPO
4
, 1.0 g L−1; NaH2PO4 × H2O, 0.4 g L
−1; MgSO4 ×
7H2O, 0.5 g L
−1; yeast extract, 2.0 g L−1; pH 6.5) with 25
mycelial disks (Ø 0.5 cm, from 7-day-old culture from malt
agar) in 250mL flasks and incubation on a rotary shaker at
100 rpm, at room temperature (22 ± 2∘C) for 7 d. The resul-
tant biomass was washed and homogenized with 100.0mL
of sterile distilled water (dH
2
O) in a laboratory blender.
Homogenized biomass (30.0mL) was used for inoculation of
500.0mL modified synthetic medium (with glucose present
at 65.0 g L−1). Submerged cultivation was carried out in
1000mL flasks at room temperature on a rotary shaker for
21 d. The obtained biomass was filtered, washed 3 times with
dH
2
O on a magnetic stirrer, and dried at 50∘C to constant
weight.
2.2. Preparation of the Fungal Extracts. Dried fruiting body
and mycelium (3.0 g) were extracted by stirring with 90.0mL
of 96% ethanol at 30∘C for 72 h. The resulting extracts were
centrifuged (20∘C, 3000 rpm, 15min) and supernatants were
filtered through Whatman number 4 filter paper, concen-
trated under reduced pressure in a rotary evaporator (BU¨CHI
R-114, Switzerland) at 40∘C to dryness, and redissolved in
96% ethanol for antioxidant assay [29] or water for antigeno-
toxic assay [30] to an initial concentration of 20.0mgmL−1.
The extraction yield was expressed as percentage on a dry
weight basis.
2.3. Genoprotective Activity
2.3.1. Subjects. Heparinized whole blood samples were
obtained by venipuncture from three healthy donors aged
under 25. Participants of the study were nonsmokers and
nonalcoholics, not receiving any therapy or medications and
not taking dietary supplements.
2.3.2. Study Design. Genotoxicity of all extracts and concen-
trations (20.0, 10.0, 5.0, 2.5, 1.25, 0.625, and 0.312mgmL−1)
was studied by treatment of human peripheral white blood
cells at 37∘C for 30min with the aim of evaluating DNA
damage. Normally, white blood cells are used, because they
are obtained in a relatively noninvasive way, do not require
tissue disaggregation, and behave well in the comet assay [31].
Treatment with phosphate buffered saline (PBS) at 37∘C for
30min was used as a positive control and treatment with
25.0 𝜇MH
2
O
2
on ice for 15min as a negative control.
Two independent protocols were used to assess the
antigenotoxic potential of extracts, using pretreatment and
posttreatment with the extracts. In pretreatment, the cells
were incubated with extracts at 37∘C for 30min, then washed
with PBS, and exposed to H
2
O
2
for 15min. In posttreatment,
the cells were treated with H
2
O
2
on ice for 15min, rinsed
with PBS, and subsequently treated with the seven extract
concentrations at 37∘C for 30min. After each treatment, the
cells were washed with PBS. Incubation with PBS at 37∘C for
30min was the negative control and treatment with 25.0𝜇M
H
2
O
2
on ice for 15min represented the positive control.
Three replicates were performed for each experiment and
100 nuclei were analyzed for each.
2.3.3. The Single Cell Gel Electrophoresis Assay. The comet
assay was performed as described by Singh et al. [32]. The
alkaline comet test is able to detect DNA strand breaks and
alkali-labile sites, and the extent of DNA migration indicates
the degree of DNA damage in cells.
Whole blood samples (6.0 𝜇L) were suspended in 0.67%
low-melting-point (LMP) agarose (Sigma-Aldrich, St. Louis,
MO) and pipetted onto superfrosted glass microscope slides
precoated with a layer of 1% normal-melting-point agarose
(Sigma-Aldrich, St. Louis,MO), spread using a cover slip, and
maintained on ice for 5min to solidify. After gently removing
the cover slips, the cell suspensions on slides were treated
with the extracts and H
2
O
2
as described above. Following
the treatments, all slides were covered with the third layer
of 0.5% LMP agarose and again was allowed to solidify on
ice for 5min. After removal of the cover slips, the slides
were placed in cold lysing solution (2.5M NaCl, 100mM
EDTA, 10mM Tris, 1% Triton X100, and 10% dimethyl
sulfoxide, pH 10.0 adjusted with NaOH) at 4∘C overnight
and afterwards subjected to electrophoresis and staining
with ethidium bromide [32]. The comets were observed
and analyzed using an Olympus ×50 microscope (Olympus
Optical Co., Gmbh Hamburg, Germany), equipped with
a device for recording fluorescence at 100x magnification.
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Figure 1: Categorisation of DNA damage corresponding to the amount of DNA in the tail.
Evaluation of DNA damage was performed as described by
Anderson et al. [24].Namely, cells were graded by eye into five
categories corresponding to the following amounts ofDNA in
the tail: (A) no damage, <5%; (B) low level damage, 5–20%;
(C) medium level damage, 20–40%; (D) high level damage,
40–95%; (E) total damage, >95% (Figure 1). Analysis was
performed on 100 randomly selected cells per subject (50 cells
from each of 2 replicate slides). To obtain semiquantitative
analysis of data, DNA damage was characterized as DNA
migration over 5% (B + C + D + E comet classes).
2.4. Antioxidant Activity
2.4.1. DPPH∙ Assay. Antioxidant activity was defined by
measuring bleaching of the purple-coloredmethanol solution
of stable 1,1-diphenyl-2-picrylhydrazyl radical (DPPH∙) [33].
Scavenging effects were measured spectrophotometrically
(CECILCE 2501) at 517 nmand calculated using the equation:
DPPH∙ scavenging effect (%)
= [(𝐴0 −𝐴 sample)𝐴0
−1
] × 100,
(1)
where𝐴0 is absorbance of the negative control (reactionmix-
ture without extract) and 𝐴 sample is absorbance of reaction
mixture.
Extract concentration (mg extract/mL) providing 50% of
DPPH∙ reduction (EC
50
) was obtained by interpolation from
linear regression analysis. All the measurements were carried
out in triplicate for statistical analysis. Commercial antiox-
idant, butylated hydroxyanisole (BHA), in a concentration
range of 20.0mgmL−1–0.02mgmL−1, was used as a positive
control.
2.4.2. Determination of Total Phenol Content. Total phenol
compounds in the mycelial extracts were estimated with
Folin-Ciocalteu reagent according to themethod of Singleton
and Rossi [34], using gallic acid as a standard.The concentra-
tion was determined as 𝜇g of gallic acid equivalents (GAE)
per mg of dry extract, using an equation that was obtained
from a standard gallic acid graph as
Absorbance = 0.012
× total phenols (𝜇g of gallic acid)
− 0.029 (𝑅2 = 0.999) .
(2)
2.4.3. Determination of Total Flavonoid Content. Total
flavonoid content was determined by the methods of Park
et al. [35] using quercetin as the standard. The amount was
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expressed as 𝜇g of quercetin equivalents (QE) per mg of
dry extract, using an equation obtained from a standard
quercetin hydrate graph as
Absorbance
= 0.011
× total flavonoids (𝜇g of quercetin hydrate)
+ 0.080 (𝑅
2
= 1.0) .
(3)
2.5. Statistical Analysis. The results were expressed as the
mean ± standard error of data obtained from three parallel
measurements. One-way analysis of variance (ANOVA) was
performed using STATISTIKA software, version 5.0 (StatSoft
Inc.) to test any significant differences. 𝑃 values less than
0.01 were considered statistically significant. The statistical
analysis of data from the comet assay was performed by 𝜒2
test using Statgraph 4.2 software. To perform 𝜒2 test, results
from the three experiments were pooled and we evaluated
total number of cells with DNA damages. A difference at
𝑃 < 0.05 was considered statistically significant.
3. Results and Discussion
3.1. Extraction Yield. Extraction yields of mycelium biomass
for all three species were significantly higher compared with
the fruiting body (𝑃 < 0.01). T. gibbosa had the highest
extraction yield from dried mycelium biomass (34.6%) and
the lowest yield fromdried fruiting bodies (2.2%).Thehighest
fruiting body extraction yield of 6.67% was found in T.
versicolor, whose mycelium extraction yield was 8.0%. Yields
in T. hirsuta were 12.0% (for mycelium) and 2.85% (for
fruiting body). Differences in extraction efficiency among
the species, for both mycelium and fruiting body, were
statistically significant (𝑃 < 0.01).
Previous reports showed the dependence of biomass
extractability on species, strain, and solvent [36–38]. Thus,
Ren et al. [37] found that extraction yields of T. gibbosa
basidiocarp were 1.22% for petroleum ether extract, 6.44%
for ethyl acetate, and 9.2% for methanol extracts. Methanol
was also a good solvent for T. versicolor basidiocarp whose
yield ranged between 4.1% and 9.16% [36, 38]. Based on our
results, it can be concluded that alcohols are the best solvents,
but ethanol is weaker than methanol.
3.2. Genoprotective Activity. As all blood donors were of good
health and similar age and under no medication, the statisti-
cal analysis showed no clear differences in their responses to
extracts. Therefore, results from the three experiments were
pooled. Treatment of peripheral blood leukocytes with H
2
O
2
caused a quick and powerful induction of single strand breaks
in the nuclear DNA, which was visible in the comet assay as
DNA migration.
Our results demonstrated that T. versicolor fruiting body
extracts from 0.312 to 20.0mgmL−1 caused no significant
increase in the total number of DNA-damaged cells com-
pared with the positive control, which clearly shows that the
tested extract was not a genotoxic agent (Figure 2(a) (A)).The
distribution (value) of total DNA damage was also the same
as in the positive control. On the other hand, these extracts
showed protective effects against H
2
O
2
both in pre- and
posttreatment of leukocytes (Figure 2(a) (B, C)). The extract
at 5.0mgmL−1 had the greatest effect and at 20.0mgmL−1
the lowest effect in both treatments. The value of total DNA
damage statistically decreased compared with the positive
control in all concentrations (𝑃 < 0.05).
T. hirsuta fruiting body extract at all concentrations
except 20.0mgmL−1 showed no genotoxic activity as the
level of total DNA damage was not statistically higher than
that in the positive control (Figure 2(b) (A)). However, at a
concentration of 20.0mgmL−1, the genotoxic effect and total
DNA damage in cells were statistically different compared
with the positive control. In pre- and posttreatments of
leukocytes, the extract at all concentrations except the highest
one exhibited a protective effect against H
2
O
2
-induced DNA
damage, showing significant decrease of total DNA damage
compared with the positive control (Figure 2(b) (B, C)).
These treatments displayed a dose-dependent correlation,
with the greatest protective effect at an extract concentration
of 0.312mgmL−1 while the concentration of 20mgmL−1
showed no protection against comets induced by H
2
O
2
.
The absence of a genotoxic as well as significant antigeno-
toxic effect, that is, reduction of DNA damage induced by
H
2
O
2
, in both pre- and posttreatment, was also noted for
T. gibbosa fruiting body extract at the seven concentrations
(Figure 2(c)). However, contrary to T. hirsuta extracts, a
dose-dependent response was not observed in T. gibbosa
basidiocarp extracts; namely, a gradual decrease of extract
concentration did not correspond with a proportional reduc-
tion of H
2
O
2
-induced genotoxicity.
The mycelium extracts of T. versicolor, T. hirsuta, and
T. gibbosa, at all analyzed concentrations, had no genotoxic
activity (Figures 3(a) (A), 3(b) (A), and 3(c) (A)). All
mycelium extracts and concentrations showed a significant
antigenotoxic effect against the H
2
O
2
-induced DNA damage,
both in pre- and posttreatment, and these activities were not
markedly different. In T. versicolor, a slightly lower activity
was noted at the lowest extract concentration. In T. hirsuta,
concentrations of 5.0, 2.5, and 20.0mgmL−1 were more
effective, while in T. gibbosa the greatest protective effect was
observed at a concentration of 2.5mgmL−1 and the lowest
one at 20.0mgmL−1 (Figures 3(a) (B, C), 3(b) (B, C), and 3(c)
(B, C)).
Numerous mutagenic and carcinogenic compounds are
present in different natural sources [39]. On the other hand,
somenatural compounds could be either prooxidants causing
genotoxic and/or cytotoxic effects or antioxidants, depend-
ing on the concentration and duration of exposure [40–
43]. Highly nutritional and medicinally valued mushroom
species may have different in vitro and in vivo effects due to
either their instability under digestion conditions or inability
of absorption by the gastrointestinal tract [44]. Namely,
activities obtained in vitro do not necessarily correspond to
those found in vivo. It is also important to emphasize that
genotoxic and antigenotoxic effects of mushroom extracts
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Figure 2: Effect of fruiting body extracts of (a) Trametes versicolor, (b) T. hirsuta, and (c) T. gibbosa: (A) genotoxic, (B) antigenotoxic,
pretreatment, and (C) antigenotoxic, posttreatment. Three independent experiments with three replicates per experiment were done and
evaluated by comet assay. 100 nuclei per each replicate were analyzed. Data represent total number of cells with DNA damage.
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Figure 3: Effect of mycelium extracts of (a) Trametes versicolor, (b) T. hirsuta, and (c) T. gibbosa: (A) genotoxic, (B) antigenotoxic,
pretreatment, and (C) antigenotoxic, posttreatment. Three independent experiments with three replicates per experiment were done and
evaluated by comet assay. 100 nuclei per each replicate were analyzed. Data represent total number of cells with DNA damage.
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Table 1: Total phenol and flavonoid content in ethanolic extracts of selected Trametes species.
Tested species Extract Total phenol content Total flavonoid content
(𝜇gGAE/mg of dried extract) (𝜇gQE/mg of dried extract)
Trametes gibbosa Basidiocarp 20.07 ± 1.24 7.63 ± 0.08
Mycelium 12.08 ± 0.87 1.76 ± 0.03
Trametes hirsuta Basidiocarp 21.53 ± 2.36 8.28 ± 0.05
Mycelium 14.27 ± 0.92 2.21 ± 0.02
Trametes versicolor Basidiocarp 24.80 ± 0.42 10.79 ± 0.09
Mycelium 18.06 ± 0.33 4.16 ± 0.02
depend on species, concentration, and the assay used for their
assessment [44–47].Thus, our results demonstrated different
capacities of the three Trametes species for decreasing H
2
O
2
-
induced DNA damage; for example, the lowest activity was
noted in fruiting body extract of T. hirsuta. A clear inverse
dose-response relationship between the level of DNAdamage
and extract concentration was noted only in T. hirsuta
basidiocarp extract. However, in T. versicolor and T. gibbosa,
increasing the extract concentration above the optimal dose
did not lead to any improvement in comet results which
confirms results of Miyaji et al. [40]. These authors showed
the absence of a dose-response relationship between Lenti-
nus edodes extract concentrations and their antigenotoxic
effect. It is important to mention that combined phenolic,
flavonoid, and other ingredients in extracts should have
greater potential than individual components of extracts,
indicating the significance of coactions of all ingredients [48].
That finding could result in different trend of Trametes spp.
antigenotoxic activity. Dependence of the genotoxic activity
of the extract on the assay type was demonstrated byMorales
et al. [47]; that is, they reported absence of mutagenic effect
of basidiocarp extracts of Lactarius deliciosus, Boletus luteus,
Agaricus bisporus, and Pleurotus ostreatus on mammalian
cells using the Ames Salmonella/microsome test. However, a
weak activity of P. ostreatus extract was obtained using the
CHO/HPRT assay.
The underlyingmechanisms of the antigenotoxic effect of
mushroom extracts are still not completely known. Protective
effects of the extracts seem to be based on more than
one mechanism of action, which is not uncommon for
mushrooms according to Gebhart [49]. The antigenotoxicity
mechanisms could be evaluated by applications of pre- and
posttreatments, that is, diverse combinations of extracts
and H
2
O
2
. Our positive results in both treatments indicate
that extracts have protective effects at both the prevention
and intervention levels and may act as desmutagens and
bioantimutagens, also demonstrated by previous studies [50–
52]. Efficiency of pretreatment, noted in the present study,
could be explained by increasing the antioxidant capacity
of cells, that is, stimulating the synthesis and activity of
antioxidant enzymes during the induction of oxidative stress
[53].The positive effect of posttreatment could be the result of
synergistic action of interventional activities via free radical
scavenging and stimulation of antioxidant enzymes, as well
as excitation of DNA repair, as suggested by Chiaramonte et
al. [54]. As these authors reported significant DNA damage
repair after 30–60min of exposure to an oxidative agent, it
could be concluded that DNA repair played a less signif-
icant role in protection against H
2
O
2
since posttreatment
conditions considered up to 30min of incubation.Therefore,
the genoprotective activity of the Trametes spp. extracts is
probably based on antioxidant actions. On the other hand, it
is known that eukaryotic organisms have evolved a signaling
pathway, called the DNA damage response, to protect against
genomic insults. Gasser and Raulet [22] demonstrated that
the DNA damage response alerts the immune system by
inducing expression of cell surface ligands for the activating
immune receptor NKG2D, which is expressed by natural
killer cells (NK cells) and some T cells. Therefore, the
genoprotective activity of Trametes spp. in the cells exposed
to genotoxic agents could modulate DNA damage response
and function as a barrier in early tumorigenesis. The further
researches should include analysis of superoxide dismutase
and catalase levels in lymphocytes treated with Trametes spp.
extracts, both in pre- and posttreatment with H
2
O
2
, in order
to confirm assumption that enhancement of antioxidant
capacity in cells is induced by those extracts.
3.3. Antioxidant Activity. The tested ethanol extracts were
good antioxidants but their activity depended on species.
Fruiting body extracts showed significantly higher scaveng-
ing effects than mycelium extracts (𝑃 < 0.01). The highest
DPPH radical scavenging activity was detected inT. versicolor
extracts, both fruiting body andmycelium (63.5% and 59.4%,
resp.) which was confirmed by EC
50
values (15.22mgmL−1
and 16.18mgmL−1, resp.). A slightly lower level of activity
was found for T. hirsuta extracts (59.0% for basidiocarps and
46.8% formycelium), whose concentrations of 17.06mgmL−1
and 21.81mgmL−1, respectively, provided a 50% reduction
of radicals. T. gibbosa was the species with the lowest
DPPH∙ scavenging potential, especially of mycelium extracts
(39.7%) with EC
50
value of 26.15mgmL−1. However, the
radical scavenging ability of the fruiting body extract was not
significantly lower in comparison with the other two species
(53.7% and EC
50
of 18.13mgmL−1). The DPPH∙ scavenging
activity of synthetic antioxidant BHA was 94.28%, and a
concentration of 0.10mgmL−1 provided DPPH∙ reduction of
50%.
Total phenol contents in fruiting body and mycelium
extracts of Trametes species were significantly different (𝑃 <
0.01) (Table 1). Generally, phenol contents in fruiting body
extracts were higher than in mycelium extracts.
Both T. versicolor basidiocarp and T. versicolor mycelium
extracts were the richest with phenols and flavonoids, while
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the lowest concentrations were measured in T. gibbosa
extracts. According to the phenol and flavonoid concentra-
tions, extracts of T. hirsuta came between the other two
species extracts (Table 1). The degree of correlation between
the DPPH∙ scavenging activity of the extracts and phenol and
flavonoid contents was high with 𝑅2 for fruiting bodies of
0.98 and 0.99, respectively, and formycelium of 0.97 and 0.99,
respectively.
Previous studies have also indicated the antioxidant
potential of Trametes species [17, 55, 56]. Thus, Kamiyama et
al. [56] demonstrated that an extract concentration of even
0.5mgmL−1 scavenged nearly 50% of DPPH∙ depending
on the solvent, while Johnsy and Kaviyarasana [55] noted
reduction of even 91.5% radicals by a methanol extract of
T. gibbosa basidiocarps at a concentration of 1.0mgmL−1.
Ethanol extracts tested in our study had slightly lower
capacities, but higher than ethanol T. hirsuta fruiting body
extracts analyzed by Sheikh et al. [17].
According to Mau et al. [57] and Palacios et al. [58],
phenolic compounds play a key role in antioxidative activity.
These compounds are very abundant and important con-
stituents of mushroom fruiting bodies and mycelia. Their
ability is based on the presence of hydroxyl groups acting as
reducing agents, metal chelators, singlet oxygen quenchers,
and hydrogen donors [59]. However, in some cases their
activity could not be attributed to the total phenol content
in extracts, which is confirmed by comparison of our results
with those of Johnsy and Kaviyarasana [55]. Namely, 91.5%
of DPPH∙ was reduced by T. gibbosa basidiocarp extract
containing 23.8 𝜇g GAE mg−1 extract, while an extract of
strain BEOFB 310 with a phenol concentration of 20.07𝜇g
GAE mg−1 extract scavenged only 63.5% radicals. However,
the concentration of flavonoids in the Serbian T. gibbosa
strain was significantly higher compared with the strain
tested by Johnsy and Kaviyarasana [55] (7.63 𝜇g QE mg−1 of
extract and 0.59𝜇g QE mg−1 of extract, resp.), and this could
be explained by the various polarities of solvents as well as
different strain capacity for flavonoid synthesis [60].
4. Conclusion
The study was the first attempt to assess the DNA protective
activity of T. versicolor, T. hirsuta, and T. gibbosa extracts
and determines whether this was based on their antioxidant
potential. The results suggest that extracts of these three
species could be considered as strong antigenotoxic agents
able to stimulate genoprotective response of cells contributing
to enhanced immune function, toxin removal, and strength-
ening, which refers to the traditional use. However, further
investigations are necessary to reveal specific carriers of the
antigenotoxic activity and the mode of DNA protection from
oxidative damage.
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